StreetInsider

• Log in to your account:

  
  Log in
• Signup
• Home
• EPS Insider
• Event Calendar
• Conferences
• Classic Site

Upgrade to SI Premium - Free Trial

Krystal Biotech (KRYS)

Krystal Biotech (KRYS) PT Raised to $204 at Stifel April 15, 2024 4:25 PM - StreetInsider Form DEFA14A Krystal Biotech, Inc. April 4, 2024 4:10 PM - SEC Filing Form DEF 14A Krystal Biotech, Inc. For: Apr 04 April 4, 2024 4:09 PM - SEC Filing Krystal Biotech to Present at the American Association for Cancer Research 2024 Annual Meeting April 4, 2024 7:00 AM - StreetInsider Krystal Biotech (KRYS) Enhances Clinical and Development Expertise with Appointment of Chief Medical Officer and Clinical and Scientific Advisory Boards March 26, 2024 7:02 AM - StreetInsider Attovia Enhances Clinical and Development Expertise with Appointment of Chief Medical Officer and Clinical and Scientific Advisory Boards March 26, 2024 7:00 AM - StreetInsider Form 4 Krystal Biotech, Inc. For: Mar 11 Filed by: Krishnan Suma March 11, 2024 8:27 PM - SEC Filing Form 4 Krystal Biotech, Inc. For: Mar 11 Filed by: Krishnan Krish S March 11, 2024 8:25 PM - SEC Filing Form 144 Krystal Biotech, Inc. Filed by: Krishnan Suma March 11, 2024 4:38 PM - SEC Filing Form 144 Krystal Biotech, Inc. Filed by: Krishnan Krish S March 11, 2024 4:37 PM - SEC Filing Form 4 Krystal Biotech, Inc. For: Feb 28 Filed by: ROMANO KATHRYN March 1, 2024 8:20 PM - SEC Filing Form 4 Krystal Biotech, Inc. For: Feb 28 Filed by: ROMANO KATHRYN March 1, 2024 8:17 PM - SEC Filing Form 4 Krystal Biotech, Inc. For: Feb 28 Filed by: Krishnan Suma March 1, 2024 8:14 PM - SEC Filing Form 4 Krystal Biotech, Inc. For: Feb 28 Filed by: Krishnan Krish S March 1, 2024 8:09 PM - SEC Filing Form 4 Krystal Biotech, Inc. For: Feb 26 Filed by: Krishnan Suma February 28, 2024 9:41 PM - SEC Filing Form 4 Krystal Biotech, Inc. For: Feb 26 Filed by: Krishnan Krish S February 28, 2024 9:38 PM - SEC Filing Form 4 Krystal Biotech, Inc. For: Feb 26 Filed by: ROMANO KATHRYN February 28, 2024 9:35 PM - SEC Filing Form 144 Krystal Biotech, Inc. Filed by: ROMANO KATHRYN February 28, 2024 4:43 PM - SEC Filing Krystal Biotech to Present at TD Cowen 44th Annual Health Care Conference February 28, 2024 7:00 AM - StreetInsider Krystal Biotech (KRYS) PT Raised to $200 at H.C. Wainwright February 27, 2024 6:39 AM - StreetInsider Krystal Biotech (KRYS) PT Raised to $195 at Citi February 26, 2024 4:02 PM - StreetInsider Form 144 Krystal Biotech, Inc. Filed by: ROMANO KATHRYN February 26, 2024 1:35 PM - SEC Filing Evercore ISI Removes Krystal Biotech (KRYS) From Tactical Outperform List February 26, 2024 11:26 AM - StreetInsider Krystal Biotech, Inc. (KRYS) Tops Q4 EPS by 59c February 26, 2024 8:09 AM - StreetInsider Form 8-K Krystal Biotech, Inc. For: Feb 26 February 26, 2024 8:05 AM - SEC Filing Form S-8 Krystal Biotech, Inc. February 26, 2024 8:00 AM - SEC Filing Krystal Biotech Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updates February 26, 2024 8:00 AM - StreetInsider Form 10-K Krystal Biotech, Inc. For: Dec 31 February 26, 2024 7:50 AM - SEC Filing Krystal Biotech to Report Fourth Quarter and Full Year 2023 Financial Results on February 26, 2024 February 20, 2024 7:00 AM - StreetInsider Form SC 13G/A Krystal Biotech, Inc. Filed by: Redmile Group, LLC February 14, 2024 4:27 PM - SEC Filing Form SC 13G/A Krystal Biotech, Inc. Filed by: Avoro Capital Advisors LLC February 14, 2024 9:26 AM - SEC Filing Form SC 13G Krystal Biotech, Inc. Filed by: VANGUARD GROUP INC February 13, 2024 5:12 PM - SEC Filing Krystal Biotech (KRYS) Granted FDA Fast Track Designation for KB707 February 13, 2024 7:00 AM - StreetInsider Krystal Biotech Receives FDA Fast Track Designation for Inhaled Oncology Candidate KB707 to Treat Solid Tumors of the Lung February 13, 2024 7:00 AM - StreetInsider Form SC 13G/A Krystal Biotech, Inc. Filed by: FMR LLC February 12, 2024 12:04 PM - SEC Filing Form SC 13G/A Krystal Biotech, Inc. Filed by: FMR LLC February 9, 2024 9:16 AM - SEC Filing Krystal Biotech (KRYS) Reports Publication on the Application of B-VEC to Treat Ocular Complications in Patient with Dystrophic Epidermolysis Bullosa February 8, 2024 7:03 AM - StreetInsider Krystal Biotech Announces Publication in the New England Journal of Medicine on the Application of B-VEC to Treat Ocular Complications in Patient with Dystrophic Epidermolysis Bullosa February 8, 2024 7:00 AM - StreetInsider Evercore ISI Adds Krystal Biotech (KRYS) to Tactical Outperform List February 2, 2024 6:15 AM - StreetInsider Krystal Biotech to Present at Guggenheim 6th Annual Biotechnology Conference February 1, 2024 7:00 AM - StreetInsider Form SC 13G/A Krystal Biotech, Inc. Filed by: BlackRock Inc. January 29, 2024 3:27 PM - SEC Filing Form 4 Krystal Biotech, Inc. For: Jan 22 Filed by: Romano Kathryn January 24, 2024 5:45 PM - SEC Filing Form 144 Krystal Biotech, Inc. Filed by: Romano Kathryn January 22, 2024 11:44 AM - SEC Filing Full Article List